Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors

This cohort study examines the association of BRCA1 and BRCA2 with tumor mutation burden and response to immune checkpoint inhibitors.

Detalles Bibliográficos
Autores principales: Zhou, Zhijun, Li, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105747/
https://www.ncbi.nlm.nih.gov/pubmed/33961040
http://dx.doi.org/10.1001/jamanetworkopen.2021.7728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105747/
https://www.ncbi.nlm.nih.gov/pubmed/33961040
http://dx.doi.org/10.1001/jamanetworkopen.2021.7728

Ejemplares similares